An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease

  • Gregory M. Chronowski
  • , Richard B. Wilder
  • , Susan L. Tucker
  • , Chul S. Ha
  • , Andreas H. Sarris
  • , Fredrick B. Hagemeister
  • , Ibrahim Barista
  • , Mark A. Hess
  • , Fernando Cabanillas
  • , James D. Cox

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease'. Together they form a unique fingerprint.

Medicine and Dentistry